Results 231 to 240 of about 883,016 (338)
Molecular Mechanisms of Chronic Intestinal Diseases in Response to Microbiota. [PDF]
Grasa L.
europepmc +1 more source
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim +18 more
wiley +1 more source
Research progress of polysaccharide drug delivery systems in the treatment of intestinal diseases: A review. [PDF]
Dong L +6 more
europepmc +1 more source
Prospective Evaluation of Transabdominal Bowel Sonography in the Diagnosis of Intestinal Obstruction in Crohnʼs Disease: Comparison with Plain Abdominal Film and Small Bowel Enteroclysis [PDF]
Anna Kohn +4 more
openalex +1 more source
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli +8 more
wiley +1 more source
Energy metabolism and the intestinal barrier: implications for understanding and managing intestinal diseases. [PDF]
Chen S +11 more
europepmc +1 more source
Objective We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source

